Navigation Links
Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
Date:2/4/2010

DURHAM, N.C., Feb. 4 /PRNewswire/ -- Gorbec Pharmaceutical Services, a rapidly expanding contract developer and manufacturer of prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory in Yantai, China.  This new facility will expand Gorbec's current services for analytical method development and testing.  Gorbec is taking this action to better serve its U.S. customer base as well as develop a presence in the emerging Asian market.

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for U.S.-based customers.  Gorbec's future plans call for an increased capacity to develop and submit New Drug Applications (NDA'S) and will require an expansion of analytical services.  In an effort to improve efficiencies and reduce costs, the company has elected to locate the new analytical facility in China.  The company's core business services, current analytical laboratory, and commercial manufacturing will remain in the U.S.  The China facility is expected to open May 1st, 2010 but Gorbec is already working with customers who have plans to use some of the new facility's capacity.

The Yanti facility will operate under the direction of Gorbec's Vice President of Analytical Chemistry, Dr. Jing Chen.  Dr. Chen received her PhD from Stanford University and brings a wealth of pharmaceutical experience to the operation.  She joined Gorbec after holding various positions at Genentech Inc. and Alza Corporation.  Working with Dr. Chen will be Yan Zhang who will oversee the daily operations locally in Yantai.

Gorbec's Founder and CEO, Mike Gorma
'/>"/>

SOURCE Gorbec Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
2. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
3. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
7. Americas Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
8. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
9. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
10. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Laboratory (IL) today announced the launch of its new corporate ... of a comprehensive rebranding effort by Werfen, the parent company ... , in 1959, IL has been part of the ... the group include Inova Diagnostics ( San Diego, CA ... ).  Like IL, these three companies are focused on ...
(Date:7/29/2014)... TORONTO , July 29, ... ESAQ), an emerging pharmaceutical company exploring drug ... novel formulations and alternative dosage forms of ... its pharmaceutical development implementing its sub-micron platform technology.  ... drugs that will address indications in diabetes ...
(Date:7/29/2014)... -- Research and Markets has announced the ... report to their offering. ... a medical device used to provide medication or assist ... cannot achieve adequate oxygen levels to maintain life. Patients ... and ARDS require the need of respiratory devices. The ...
Breaking Medicine Technology:Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Global Respiratory Devices Market 2014-2018 2
... Food and Drug Administration (FDA) says children and pets should not come in contact with ... menopause. , , , ... , , ... , The agency also wants ...
... AUSTIN, Texas ,  July 29 Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics ... issuance of Q2 financial results on Monday, August 16, 2010 . , ... Conference Call Information , , ... live conference call via phone, dial (800) 757 8521 from the United States ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3
(Date:7/29/2014)... The report “Cloud Database and DBaaS Market ... Data Scaling and Replication, Back-Up and Recovery, Database ... Models (Public Cloud, Private Cloud, Virtual Private Cloud, ... Large) - Global Advancements, Market Forecasts and Analysis ... and DBaaS market into various sub-segments with in-depth ...
(Date:7/29/2014)... principle suitable to find out which preferences patients have ... health economic evaluations, some (primarily methodological) issues still need ... pilot project by the German Institute for Quality and ... Process (AHP), CA is the second method tested by ... outcome-specific results to an overall value , In ...
(Date:7/29/2014)... 29, 2014 A simplified anesthesia procedure may enable ... cause of airway obstruction in patients with severe sleep ... . , Dr. Joshua H. Atkins and Dr. Jeff ... colleagues have developed a new "ramp control" anesthetic technique ... the "obstructive anatomy" responsible for sleep apnea. The simplified ...
(Date:7/29/2014)... studies have repeatedly shown that death rates rise in ... Western Europe in the summer of 2003, for example, ... researchers led by Dr. Alex-andra Schneider at the Institute ... the impact of extreme temperatures on the number of ... and included both high and low temperatures in the ...
(Date:7/29/2014)... future in which a new lung is grown for a ... a day when an injection of replacement cells will enable ... other tissues. , MULTIMEDIA ALERT: For audio and video of ... regenerative medicine, visit the Mayo Clinic News Network . ... fiction, and a substantial gift from Jorge and Leslie Bacardi ...
Breaking Medicine News(10 mins):Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Determine patient preferences by means of conjoint analysis 2Health News:Determine patient preferences by means of conjoint analysis 3Health News:Determine patient preferences by means of conjoint analysis 4Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 3Health News:Mortality rates increase due to extreme heat and cold 2Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 2Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 3Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 4
... ... a featured expert on searchbloodsugar.com, a new informational Web site devoted to all aspects ... ... Dr. David Williams , a clinician, author, publisher, entrepreneur, world researcher, and scientist, is ...
... , WASHINGTON, July 15 On behalf ... Director Tom Cochran today commended President Barack Obama, the House of ... towards passing comprehensive and transformative health care reform legislation. ... during these difficult economic times because they are not able to ...
... Former Vermont Governor to sign new book on healthcare reform , ... Howard Dean will appear Barnes and Noble,s Union Square location in New York ... ( www.deanshealthcare.com ). During his appearance Dean will make brief remarks ... book. , , Dean has been traveling ...
... , HARRISBURG, Pa., July 15 The Department of ... air quality action day for June 16 in the Philadelphia region. ... forecast predicts Thursday will be code ORANGE for ozone in the ... , , The U.S. Environmental ...
... , , , ... AHS ), the leading healthcare staffing company in the United States, ... Financial Officer (CFO), effective August 10, 2009. Bailey brings nearly 30 ... insurance and pharmaceutical industries. , , Mr. ...
... , , TEGUCIGALPA, Honduras, ... rehabilitation and education program has many outreach activities, but none may be ... to glue in Honduras. , , *(PHOTO ... of the Honduras orphaned children being helped. Credit: Narconon.) , ...
Cached Medicine News:Health News:Dr. David Williams Featured on Searchbloodsugar.com 2Health News:The Nation's Mayors Commend New Healthcare Reform Legislation 2Health News:Governor Howard Dean to Appear at Barnes and Noble in Union Square 2Health News:Air Quality Action Day Forecast for July 16 in Philadelphia Region 2Health News:AMN Healthcare Names New Chief Financial Officer 2Health News:AMN Healthcare Names New Chief Financial Officer 3Health News:Narconon of Georgia Saves Lives of Orphaned Children in Honduras 2
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
Finesse electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
The Aaron 800-EU is designed and engineered to be the most reliable and durable desiccator available today....
Medicine Products: